Login / Signup

Changes in immune cell populations following KappaMab, lenalidomide and low-dose dexamethasone treatment in multiple myeloma.

Samuel E NortonTiffany KhongMalarmathy RamachandranAndrew J HightonKirsten A Ward-HartstongeJake ShorttAndrew SpencerRoslyn A Kemp
Published in: Clinical & translational immunology (2023)
immune cells.
Keyphrases
  • multiple myeloma
  • low dose
  • high dose
  • stem cell transplantation
  • newly diagnosed
  • combination therapy
  • replacement therapy